Primary care research explores diseases and treatments that are important and relevant to patients. Evidence based practice plays a vital role in delivering best clinical and holistic care.
We are RCGP accredited “Research Ready” organisation and delighted to be working with National Institute of Health Research (NIHR) Clinical Research Networks (CRN).
We are actively recruiting patients for the studies below.
Current Studies – Active Recruitment
East London Genes and Health
South Asian people have some of the highest rates of heart disease, diabetes, and poor health in the UK. Living with a long term illness has a major impact on a person’s quality of life and on their family.
East London Genes and Health is a medical research study set up to help fight against these and other major diseases.
The primary objective of the research is to investigate and understand why some individuals have a disease, and help suggest how new medicines and treatments might be developed.
Acronym. i Adhere to Medication
In England, there are 13.5 million adults diagnosed with Hypertension and more than 5.5 million are undiagnosed. Hypertension(High Blood Pressure; HBP) accounts for 75,000 deaths, and is often accompanied with diabetes type 2 (DT2), cholesterol, and other health problems.
Hypertension is a major risk factor for disability and premature deaths, and medication adherence can considerably lower these risks.
The primary objective of the research is to assess the feasibility of face to face and digital intervention to support adherence to anti-hypertensive medications and improve blood pressure in primary care.
Acronym. Aspirin To Target Arterial Chronic Kidney Disease
In patients with cardiovascular disease (CVD), there is good evidence that antiplatelet therapy reduces the risk of subsequent vascular events (secondary prevention), and that overall these benefits outweigh the risks of major bleeding, which is the principle complication of therapy.
There is currently insufficient evidence to recommend the use of aspirin for the primary prevention of CVD in chronic Kidney Disease (CKD).
The primary objective of the research is to test the hypothesis that low-dose (75mg non-enteric coated) aspirin reduces the risk of major vascular events (excluding confirmed intracranial haemorrhage) (primary endpoint) in people with CKD who do not have pre-existing CVD.
Acronym. Cancer: Life Affirming Survivorship support in Primary Care
There is currently an unmet need for tailored support in primary care for cancer survivors to improve their quality of life.
The primary objective of the research is to assess the feasibility of an online intervention called ‘Renewed’ that offers lifestyle and wellbeing support for cancer survivors.
Acronym. The At-Risk Registers Integrated into primary care to Stop Asthma crises in the UK
Conducted by University of East Anglia supported by NIHR and Asthma UK.
Runs a background algorithm to detect patients who at risk for severe asthma attacks and raises patient alert for reception and clinical staff.
The primary objective of the research is to reduce asthma deaths.
Previous Studies – No Active Recruitment
If you are interested in any of the studies or would like more information, please contact our research team on 01923 202 600
Dr Alex Carefull
Dr Ariff Amin
Rezwona Chowdhury - Research Nurse
Paula Hankin - Research Co-ordinator
Lisa Mackin - Practice Manager
Elizabeth Thomson- Reception Team Leader